Longevity Acquisition Corp (Nasdaq: LOAC) is a blank-check company that completed its initial public offering in 2020 with a focus on the healthcare and longevity sector, targeting businesses engaged in extending and improving human healthspan. The 10-Q filed January 13, 2021, with accession number 0001104659-21-003586, reflects the company's status during its active search phase for a merger target. LOAC sought acquisition candidates operating at the intersection of biotechnology, medical technology, and age-related therapeutics, a sector that drew significant SPAC interest during the 2020–2021 wave of blank-check issuance. Investors and analysts tracking LOAC's deal timeline and search progress can access full diligence data, filing history, and sponsor details by signing up at SpacDesk.